Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 9
Results: 18
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1451, doi. 10.1038/s41416-023-02453-1
- By:
- Publication type:
- Article
Checkpoint inhibitors and anti-angiogenic agents: a winning combination.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1367, doi. 10.1038/s41416-023-02437-1
- By:
- Publication type:
- Article
Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1510, doi. 10.1038/s41416-023-02419-3
- By:
- Publication type:
- Article
Immune check points in cancer treatment: current challenges and perspectives.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1516, doi. 10.1038/s41416-023-02420-w
- By:
- Publication type:
- Article
Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1477, doi. 10.1038/s41416-023-02418-4
- By:
- Publication type:
- Article
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1389, doi. 10.1038/s41416-023-02367-y
- By:
- Publication type:
- Article
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1462, doi. 10.1038/s41416-023-02417-5
- By:
- Publication type:
- Article
Exposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1500, doi. 10.1038/s41416-023-02411-x
- By:
- Publication type:
- Article
Advancing translational research for colorectal immuno-oncology.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1442, doi. 10.1038/s41416-023-02392-x
- By:
- Publication type:
- Article
Comprehensive analysis of the lncRNAs-related immune gene signatures and their correlation with immunotherapy in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1397, doi. 10.1038/s41416-023-02379-8
- By:
- Publication type:
- Article
Dose response relationship between breast cancer and somatotypes during childhood: a systematic review and meta-analysis.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1432, doi. 10.1038/s41416-023-02376-x
- By:
- Publication type:
- Article
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1490, doi. 10.1038/s41416-023-02416-6
- By:
- Publication type:
- Article
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1409, doi. 10.1038/s41416-023-02363-2
- By:
- Publication type:
- Article
Harnessing tumor immunity with cytotoxics: T cells monitoring in mice bearing lung tumors treated with anti-VEGF and pemetrexed-cisplatin doublet.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1373, doi. 10.1038/s41416-023-02350-7
- By:
- Publication type:
- Article
Quantitative multiplexed imaging technologies for single-cell analysis to assess predictive markers for immunotherapy in thoracic immuno-oncology: promises and challenges.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1417, doi. 10.1038/s41416-023-02318-7
- By:
- Publication type:
- Article
Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 9, p. 1383, doi. 10.1038/s41416-023-02190-5
- By:
- Publication type:
- Article